M-A | Associação de inibidores do cotransportador de sódio-glicose 2 com desfechos cardiovasculares em pacientes com diabetes tipo 2 e outros fatores de risco para doença cardiovascular.

Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease: A Meta-analysis – JAMA Network Open

Comentário no Twitter

This meta-analysis found that use of SGLT2-Is was associated with lower occurrence of cardiovascular death or hospitalization for heart failure by 33% in high-risk patients. @mukul_bhattarai @AkcharAl @AbhiKulk82 @mominsiddique01 @Mohsin_Salih19 https://t.co/omPP6Qwofg

— JAMA Network Open (@JAMANetworkOpen) January 5, 2022